The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.
Condition(s):Hemophilia BLast Updated:November 30, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hemophilia BLast Updated:November 30, 2022Not yet recruiting
Condition(s):Hemophilia BLast Updated:March 4, 2024Recruiting
Condition(s):Hemophilia BLast Updated:July 5, 2022Not yet recruiting
Condition(s):Hemophilia BLast Updated:July 1, 2022Not yet recruiting
Condition(s):Haemophilia BLast Updated:March 12, 2024Active, not recruiting
Condition(s):Hemophilia BLast Updated:February 7, 2024Active, not recruiting
Condition(s):Hemophilia BLast Updated:August 14, 2023Active, not recruiting
Condition(s):Chronic Pain; HemophiliaLast Updated:January 24, 2022Unknown status
Condition(s):Hemophilia BLast Updated:July 20, 2023Terminated
Condition(s):Hemophilia BLast Updated:January 20, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.